Literature DB >> 26997273

Merlin/NF2-Lin28B-let-7 Is a Tumor-Suppressive Pathway that Is Cell-Density Dependent and Hippo Independent.

Hiroki Hikasa1, Yoshitaka Sekido2, Akira Suzuki3.   

Abstract

Contact inhibition of proliferation is critical for tissue organization, and its dysregulation contributes to tumorigenesis. Merlin/NF2 is a tumor suppressor that governs contact inhibition. Although Merlin/NF2 inhibits YAP1 and TAZ, which are paralogous Hippo pathway transcriptional co-activators and oncoproteins, it is not fully understood how Merlin/NF2-mediated signal transduction triggered by cell-cell contact exerts tumor suppression. Here, we identify Lin28B, an inhibitor of let-7 microRNAs (miRNAs), as an important downstream target of Merlin/NF2. Functional studies revealed that, at low cell density, Merlin/NF2 is phosphorylated and does not bind to Lin28B, allowing Lin28B to enter the nucleus, bind to pri-let-7 miRNAs, and inhibit their maturation in a YAP1/TAZ-independent manner. This inhibition of pri-let-7 maturation then promotes cell growth. However, cell-cell contact triggers Merlin/NF2 dephosphorylation, which sequesters Lin28B in the cytoplasm and permits pri-let-7 maturation. Our results reveal that Merlin/NF2-mediated signaling drives a tumor-suppressive pathway that is cell-density dependent and Hippo independent.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hippo pathway; Lin28B; Merlin/NF2; cell contact; let-7; microRNA

Mesh:

Substances:

Year:  2016        PMID: 26997273     DOI: 10.1016/j.celrep.2016.02.075

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  11 in total

1.  IGF1/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells.

Authors:  Zhenjun Li; Weihuo Pan; Yi Shen; Zhiliang Chen; Lihua Zhang; Yuping Zhang; Quan Luo; Xiaojiang Ying
Journal:  Cell Cycle       Date:  2018-07-18       Impact factor: 4.534

2.  Genome-Wide CRISPR Screen for Essential Cell Growth Mediators in Mutant KRAS Colorectal Cancers.

Authors:  Edwin H Yau; Indrasena Reddy Kummetha; Gianluigi Lichinchi; Rachel Tang; Yunlin Zhang; Tariq M Rana
Journal:  Cancer Res       Date:  2017-09-27       Impact factor: 12.701

3.  Essential signaling in NF2 loss-related tumours: the therapeutic potential of CRL4DCAF1 and mTOR combined inhibition.

Authors:  Helena J Janse van Rensburg; Xiaolong Yang
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

4.  PCAF-mediated acetylation of Lin28B increases let-7 biogenesis in lung adenocarcinoma H1299 cells.

Authors:  Ting-Ting Qu; Fei Chen; Jing Wang; Yan-Jun Zhang; Mo-Bin Cheng; Wen-Zheng Sun; Yu-Fei Shen; Ye Zhang
Journal:  BMC Cancer       Date:  2018-01-04       Impact factor: 4.430

Review 5.  Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma.

Authors:  Yoshitaka Sekido
Journal:  Cancers (Basel)       Date:  2018-03-22       Impact factor: 6.639

6.  Refinement of breast cancer molecular classification by miRNA expression profiles.

Authors:  Rolf Søkilde; Helena Persson; Anna Ehinger; Anna Chiara Pirona; Mårten Fernö; Cecilia Hegardt; Christer Larsson; Niklas Loman; Martin Malmberg; Lisa Rydén; Lao Saal; Åke Borg; Johan Vallon-Christerson; Carlos Rovira
Journal:  BMC Genomics       Date:  2019-06-17       Impact factor: 3.969

7.  Merlin is required for coordinating proliferation of two stem cell lineages in the Drosophila testis.

Authors:  Mayu Inaba; Dorothy R Sorenson; Matt Kortus; Viktoria Salzmann; Yukiko M Yamashita
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

Review 8.  NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.

Authors:  Tatsuhiro Sato; Yoshitaka Sekido
Journal:  Int J Mol Sci       Date:  2018-03-26       Impact factor: 5.923

Review 9.  Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells.

Authors:  Abdulaziz B Hamid; Ruben C Petreaca
Journal:  Cancers (Basel)       Date:  2020-04-09       Impact factor: 6.639

10.  Targeting YAP1/LINC00152/FSCN1 Signaling Axis Prevents the Progression of Colorectal Cancer.

Authors:  Chunlin Ou; Zhenqiang Sun; Xiaoyun He; Xiaoling Li; Songqing Fan; Xiang Zheng; Qiu Peng; Guiyuan Li; Xiayu Li; Jian Ma
Journal:  Adv Sci (Weinh)       Date:  2019-12-05       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.